Synthetic Biologics

-$0.0697 (-9.68%) Today
+$0.0082 (+1.26%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SYN and other stocks, options, and ETFs commission-free!

About SYN

Synthetic Biologics, Inc., also called Synthetic Biologics, is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004.

CEO
Steven A. Shallcross
Employees
10
Headquarters
Rockville, Maryland
Founded
2001

SYN Key Statistics

Market Cap
85.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.75M
High Today
$0.695
Low Today
$0.6451
Open Price
$0.6911
Volume
5.69M
52 Week High
$1.70
52 Week Low
$0.261

SYN Earnings

-$0.31
-$0.21
-$0.10
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure